NKGen Biotech, Inc. Quarterly Return On Assets in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NKGen Biotech, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2021 to Q2 2024.
  • NKGen Biotech, Inc. Return On Assets for the quarter ending June 30, 2024 was -479 %, a 1022% decline year-over-year.
  • NKGen Biotech, Inc. annual Return On Assets for 2023 was -118 %, a 493% decline from 2022.
  • NKGen Biotech, Inc. annual Return On Assets for 2022 was -19.9 %, a 2531% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -479 -437 -1022% Apr 1, 2024 Jun 30, 2024
Q1 2024 -263 -236 -857% Jan 1, 2024 Mar 31, 2024
Q4 2023 -118 -98.2 -493% Oct 1, 2023 Dec 31, 2023
Q3 2023 -103 -100 -3434% Jul 1, 2023 Sep 30, 2023
Q2 2023 -42.7 -46.4 -1278% Apr 1, 2023 Jun 30, 2023
Q1 2023 -27.5 -28.1 -4670% Jan 1, 2023 Mar 31, 2023
Q4 2022 -19.9 -19.2 -2531% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.92 Jul 1, 2022 Sep 30, 2022
Q2 2022 3.63 Apr 1, 2022 Jun 30, 2022
Q1 2022 0.6 Jan 1, 2022 Mar 31, 2022
Q4 2021 -0.76 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.